674 related articles for article (PubMed ID: 22864374)
1. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
2. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
[TBL] [Abstract][Full Text] [Related]
3. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
Jost G; Pietsch H; Sommer J; Sandner P; Lengsfeld P; Seidensticker P; Lehr S; Hütter J; Sieber MA
Invest Radiol; 2009 Feb; 44(2):114-23. PubMed ID: 19104440
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
[TBL] [Abstract][Full Text] [Related]
5. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity.
Jost G; Lenhard DC; Sieber MA; Lengsfeld P; Hütter J; Pietsch H
Invest Radiol; 2011 Dec; 46(12):796-800. PubMed ID: 21808199
[TBL] [Abstract][Full Text] [Related]
6. Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats.
Seeliger E; Ladwig M; Sargsyan L; Cantow K; Persson PB; Flemming B
Invest Radiol; 2012 Apr; 47(4):240-6. PubMed ID: 22353855
[TBL] [Abstract][Full Text] [Related]
7. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination.
Jost G; Pietsch H; Lengsfeld P; Hütter J; Sieber MA
Invest Radiol; 2010 May; 45(5):255-61. PubMed ID: 20375847
[TBL] [Abstract][Full Text] [Related]
8. Viscosity of iodinated contrast agents during renal excretion.
Jost G; Lengsfeld P; Lenhard DC; Pietsch H; Hütter J; Sieber MA
Eur J Radiol; 2011 Nov; 80(2):373-7. PubMed ID: 21376497
[TBL] [Abstract][Full Text] [Related]
9. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.
Seeliger E; Becker K; Ladwig M; Wronski T; Persson PB; Flemming B
Radiology; 2010 Aug; 256(2):406-14. PubMed ID: 20529990
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
Ludwig U; Connemann J; Keller F
Clin Exp Nephrol; 2013 Dec; 17(6):779-82. PubMed ID: 23345070
[TBL] [Abstract][Full Text] [Related]
11. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
12. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
Wang YC; Tang A; Chang D; Zhang SJ; Ju S
Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
[TBL] [Abstract][Full Text] [Related]
13. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
14. Viscosity of contrast media perturbs renal hemodynamics.
Seeliger E; Flemming B; Wronski T; Ladwig M; Arakelyan K; Godes M; Möckel M; Persson PB
J Am Soc Nephrol; 2007 Nov; 18(11):2912-20. PubMed ID: 17942967
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
[TBL] [Abstract][Full Text] [Related]
16. Effects of nonionic monomeric and dimeric contrast media on the twitching reaction of the rat. Importance of osmolality and electrolyte content.
Bååth L; Besjakov J; Pettersson G
Invest Radiol; 1994 Nov; 29(11):985-9. PubMed ID: 7890513
[TBL] [Abstract][Full Text] [Related]
17. Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function.
Spasojević-Dimitrijeva B; Kotur-Stevuljević J; Đukić M; Paripović D; Miloševski-Lomić G; Spasojević-Kalimanovska V; Pavićević P; Mitrović J; Kostić M
Med Sci Monit; 2017 Sep; 23():4299-4305. PubMed ID: 28874655
[TBL] [Abstract][Full Text] [Related]
18. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
[TBL] [Abstract][Full Text] [Related]
19. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents.
Sendeski M; Patzak A; Persson PB
Invest Radiol; 2010 Aug; 45(8):453-7. PubMed ID: 20458252
[TBL] [Abstract][Full Text] [Related]
20. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
